The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

Autor: Husted, S, James, SK, Bach, RG, Becker, RC, Budaj, A, Heras, M, Himmelmann, A, Horrow, J, Katus, HA, Lassila, R, Morais, J, Nicolau, JC, Steg, PG, Storey, RF, Wojdyla, D, Wallentin, L, PLATO study group

Publikováno v: European Heart Journal

Aims The aim of this study was to assess the relationship between sex and clinical outcomes and treatment-related complications in patients with ST-elevation or non-ST-elevation acute coronary syndromes (ACS) randomized to treatment with ticagrelor o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db2489ccc03aeb7f808fc4da5dcf340e
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-229459

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.

Autor: Mehdizadeh Parizi, Mohammadjavad¹ (AUTHOR), Golchin Vafa, Reza¹ (AUTHOR), Ahmadi, Amin¹ (AUTHOR), Heydarzade, Reza¹ (AUTHOR), Sadeghi, Mehrdad¹ (AUTHOR), Khademolhossseini, Amin¹ (AUTHOR), Amiri, Farhang¹ (AUTHOR), Khoshnood Mansorkhani, Soroush¹ (AUTHOR), Tavan, Ali¹ (AUTHOR), Hosseini, Nazanin¹ (AUTHOR), Montaseri, Mohammad¹ (AUTHOR), Hosseini, Seyed Ali¹ (AUTHOR), Kojuri, Javad^1,2,3 (AUTHOR)

Publikováno v: Journal of Interventional Cardiology. 12/26/2023, p1-8. 8p.

Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) trial.

Autor: Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L, PLATO study group

Publikováno v: Circulation: Cardiovascular Quality & Outcomes; Sep2012, Vol. 5 Issue 5, p680-688, 9p

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Autor: Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L, PLATO Study Group

Publikováno v: Circulation; 11/23/2010, Vol. 122 Issue 21, p2131-2141, 11p

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.

Autor: Husted S; Medical Department, Hospital Unit West, GI, Landevej 61, Herning 7400, Denmark steehust@rm.dk., James SK; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Bach RG; Cardiovascular Division, Washington University School of Medicine, St Louis, MO, USA., Becker RC; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Heras M; Cardiology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain., Himmelmann A; AstraZeneca Research and Development, Mölndal, Sweden., Horrow J; AstraZeneca Research and Development, Wilmington, DE, USA., Katus HA; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany., Lassila R; Division of Hematology and Laboratory Services Coagulation Disorders, Helsinki University Central Hospital, Helsinki, Finland., Morais J; Santo Andre Hospital, Leiria, Portugal., Nicolau JC; Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil., Steg PG; INSERM-Unité 698, Paris, France Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France., Storey RF; Department of Cardiovascular Science, University of Sheffield, Sheffield, UK., Wojdyla D; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Wallentin L; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Publikováno v: European heart journal [Eur Heart J] 2014 Jun 14; Vol. 35 (23), pp. 1541-50. Date of Electronic Publication: 2014 Mar 28.